Achieving the Third 95: Keeping Adolescents Living with Hiv Virally Suppressed in Rural Nigeria in Test and Treat Era Using Continuous Quality Improvement Model of Peer Counseling & Support Group

Presenter
  • S. Usman
Session
Virtual 321 - AAR04 Antiviral Agents (including HIV Drugs): Mechanisms of Action and Resistance - HIV and HCV Resistance and Therapy

Previous ePoster
The Progress Towards Achieving the Unaids Ambitious 95% Viral Suppression Target among Adults Living with Hiv in South-Western Nigeria

Next ePoster
Accelerated Hiv Case Finding & Bridging Enrolment Gap for Key Populations in Western Nigeria: A Breakeven in Achieving Unaids Fast Tract 95-95-95 Targets
Colistin Resistance via Chromosomal and Plasmid-Mediated Mechanisms in Escherichia coli and Klebsiella spp. Isolated from Municipal Wastewater Influents in Japan
Role of Norovirus and Membrane Vesicles from Commensal Bacteria Interaction in Infection and Disease
The Effect of Shift Work on Chlamydial Pathogenesis
Ciprofloxacin Interactions with Hibiscus sabdariffa Extract Reveal Synergistic, Additive and Antagonistic Effects In vitro: Implications for Concommitant Use
Banking on Your Microbial Wealth: Common Ground for Senior Citizen Education
Designing an Instructional Microbial Periodic for Clinical Microbiology: Critical Thinking
Incidence of Non-ulcerative Sexually-transmitted Infections among University Students in a High-prevalence Community
Nutrient Import Through ABC Transporters is Essential for Fitness of Escherichia Coli During UTI
Novel Multidrug-Resistance Plasmid Carrying optrA Found in Enterococcus faecalis Human Clinical Isolate